Advanced Cardiovascular POC Testing System Gets FDA Clearance
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Read MorePosted by Andy Lundin | Apr 5, 2024 | Cardiovascular |
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Read MorePosted by Andy Lundin | Mar 28, 2024 | Molecular Diagnostics |
A single genetic test could potentially replace the current two-step approach to diagnosing rare developmental disorders in children.
Read MorePosted by Andy Lundin | Mar 27, 2024 | Cardiovascular, Molecular Diagnostic Analyzers |
The new high-sensitivity troponin assay is designed for use on the the PATHFAST Biomarker Analyzer from Polymedco.
Read MorePosted by Andy Lundin | Mar 25, 2024 | Unknown Origin & Other Cancer Types |
The tumor cell enumeration assay is a diagnostic test that is promising for establishing the diagnosis of leptomeningeal metastases.
Read MorePosted by Andy Lundin | Mar 22, 2024 | Unknown Origin & Other Cancer Types |
The U.S. Patent and Trademark Office issued a patent to Myriad Genetics aimed at strengthening its ability to deliver a MRD assay to market.
Read More